A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison, MD, Robin E. Rutherford, MD, Bobbi J. Woolwine, MSW, Chen Shuo, MS, Pamela Schettler, PhD, Daniel F. Drake, PhD, Ebrahim Haroon, MD, Andrew H. Miller, MD
JAMA Psychiatry. 2013;70(1):31-41.
Published online January 1, 2013
Select Pricing Criteria:
Choose criteria for pricing info
Want online access for an institution? Learn More/Request Quote >